Clinical Trial Update: Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 trial update on adherence of a 1,600 mg single-tablet 5-ASA treatment for Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 1,600 mg single-tablet 5-ASA

Snippet

Sponsor: Flemming Bendtsen | Conditions: Ulcerative Colitis | Phase 4 | Status: UNKNOWN